IBSAX | PAMCX | IBSAX / PAMCX | |
Total Expense Ratio | 1.50 | 1.01 | 149% |
Annual Report Gross Expense Ratio | 1.62 | 1.01 | 160% |
Fund Existence | 23 years | 25 years | - |
Gain YTD | -27.977 | 3.310 | -845% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 342M | 27.4B | 1% |
Annual Yield % from dividends | 0.06 | 0.00 | - |
Returns for 1 year | -27.14 | -3.25 | 835% |
Returns for 3 years | -21.50 | 12.66 | -170% |
Returns for 5 years | -32.28 | 0.49 | -6,635% |
Returns for 10 years | -46.34 | 24.99 | -185% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 40.60 | 0.51 | +1.27% |
Eventide Healthcare & Life Sciences I | |||
ZVNIX | 43.03 | 0.22 | +0.51% |
Zevenbergen Growth Institutional | |||
FKIDX | 16.79 | 0.05 | +0.30% |
Fidelity Diversified Intl K6 | |||
AGTHX | 86.22 | 0.21 | +0.24% |
American Funds Growth Fund of Amer A | |||
DNLYX | 62.46 | -0.01 | -0.02% |
BNY Mellon Active MidCap Y |